Navigation Links
Diabetes Drug, Exenatide, Good For Blood Sugar Levels and Weight Loss

Eli Lilly and and Amylin Pharmaceuticals has announced that exenatide is very effective in controlling blood sugar levels, at par with iphasic insulin // aspart 30/70 (NovoMix by NovoNordisk). This finding was revealed after a threadbare study conducted by the company. This is indeed a boon to people suffering type 2 diabetes and unable to control the blood sugar with the oral diabetes drugs.

The study, which spanned a year, revealed that thirty-two percent of study participants using exenatide were able to effectively attain the target HbA1C of 7 percent or less. HbA1C is a measure of individuals average glucose level, a gauge commonly used by the specialists. The study also revealed that many patients using exenatide also experienced weight loss, an average of 2.5 kilograms (5.5 pounds), while the patients receiving biphasic insulin aspart had actually gained an average of 2.9 kilograms (6.4 pounds).

"This comparator study demonstrates that exenatide has similar blood glucose control to the conventional treatment with insulin," said Professor Dr. Michael Nauck, Director of the Diabetes Centre in Bad Lauterberg, Germany, and a lead author of the study.

Exenatide happens to be the first among a relatively new class of medicines known as incretin mimetics, which is approved, by the U.S. Food and Drug Administration for the treatment of type 2 diabetes.
'"/>




Page: 1

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. Diabetes and Depression often go hand-in-hand
3. Thirty minutes of work up per day reduces the risk of Diabetes
4. Diabetes on the rise
5. Irregular Periods Linked to Diabetes
6. Cinnamon combats Diabetes
7. Good News For Women With Gestational Diabetes
8. Processed Meat, Diabetes connection Found
9. Pancreatic Cancer may be linked to Diabetes
10. Gestational Diabetes linked to Chromosomal defici
11. A way to slow the progression of Type 1 Diabetes

Post Your Comments:
(Date:11/8/2009)...ssage of Health Care Reform Bill ,, Critical ...erage for all Americans ,, BALTIMORE, Nov. 7 /...nited States House of Representatives passed criti...ngthen Medicare for seniors and end discrimination...ericans out of affordable health coverage. ,, T...
(Date:11/7/2009)...Newswire-USNewswire/ -- Karen Ignagni, President a... released the following statement today on House p...support comprehensive health care reform, and we h...complete overhaul of how health insurance is provi...erage, elimination of pre-existing condition exclu...
(Date:11/7/2009)...wswire-USNewswire/ -- The American Medical Associa...ard for Citizenship and Community Service to Manus...IL. The award recognizes physicians who have gone ...o make an outstanding public service contribution ...ward today during the opening session of the 2009 ...
(Date:11/7/2009)...(CT), David A. Cook (GA), Louis J. Goodman (TX), P... ,, CHICAGO, Nov. 7 ...nted five medical society executive leaders with a...the goals and ideals of the medical profession. Th...olicy making meeting in Houston. ,, (Logo: h...
(Date:11/7/2009)...swire-USNewswire/ -- Members of the AMA are trying...solution rescinding the AMA,s support of HR 3962. ... responsible to their PATIENTS, not the leadership...icy for the Association of American Physicians and...other medical groups. ,, "If the AMA leadershi...
Breaking Medicine News(10 mins):Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:AMA Honors Medical Society Executives 2
...m cells and their more committed kin, progenitor c...ability to produce different types of specialized ...r or replace damaged tissue holds great promise f...genitor cell? A team of researchers led by Berkele...
...., Feb. 27 Zimmer Holdings, Inc. (NYSE: ZMH ; S...utive Vice President and Chief Operating Officer o...d to its Board of Directors. Thermo Fisher Scient...are, and environmental, industrial and safety mark...
...rs note that exact in-flight medical emergency num...lthDay News) -- More than half of the medical emer...nting, a new study shows, but the researchers note...y data from 32 European airlines, although only fo...
...N, China, Feb. 27 /PRNewswire-Asia/ -- Winner Medi...Medical", the "Company"), a leading,manufacturer i...nd wound care,products), today announced that the ...by the patent: method for producing,spunlace non-w...
...h in Annual Net Sales Driven by Demand for Branded...m Operations, up 25% from 2007 , , - Provides 200..., CHADDS FORD, Pa., Feb. 27 Endo Pharmaceuticals ...ear ended December 31, 2008. , , Net sales for t...
..., ON, Feb. 27 /PRNewswire-FirstCall/ - Nuvo Resear...mpany focused on the research and development of d... skin using its topical and transdermal drug deliv...porate Developments:, - Presented positive Ph...
Other Medicine News:Health News:Cell microenvironments hold key to future stem cell therapies 2Health News:Cell microenvironments hold key to future stem cell therapies 3Health News:Cell microenvironments hold key to future stem cell therapies 4Health News:Cell microenvironments hold key to future stem cell therapies 5Health News:Zimmer Holdings Names Marc Casper to Board of Directors 2Health News:Zimmer Holdings Names Marc Casper to Board of Directors 3Health News:Fainting Most Common Medical Crisis on Planes 2Health News:Fainting Most Common Medical Crisis on Planes 3Health News:Fainting Most Common Medical Crisis on Planes 4Health News:Winner Medical Receives European Patent Office Approval for PurCotton(TM) Production Method 2Health News:Winner Medical Receives European Patent Office Approval for PurCotton(TM) Production Method 3Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 2Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 3Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 4Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 5Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 6Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 7Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 8Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 9Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 10Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 11Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 12Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 13Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 14Health News:Nuvo announces 2008 fourth quarter and year-end financial results 2Health News:Nuvo announces 2008 fourth quarter and year-end financial results 3Health News:Nuvo announces 2008 fourth quarter and year-end financial results 4Health News:Nuvo announces 2008 fourth quarter and year-end financial results 5Health News:Nuvo announces 2008 fourth quarter and year-end financial results 6Health News:Nuvo announces 2008 fourth quarter and year-end financial results 7Health News:Nuvo announces 2008 fourth quarter and year-end financial results 8Health News:Nuvo announces 2008 fourth quarter and year-end financial results 9Health News:Nuvo announces 2008 fourth quarter and year-end financial results 10Health News:Nuvo announces 2008 fourth quarter and year-end financial results 11Health News:Nuvo announces 2008 fourth quarter and year-end financial results 12
(Date:11/6/2009)... 6 Keryx Biopharmaceutic...call on Tuesday, November 10, 2009 at 8:30 a.m. ES...lts and business outlook for the remainder of 2009...pany, will host the call. Keryx will announce its...ase to be issued prior to the call. ,, In order...
(Date:11/6/2009)...6 Caraco Pharmaceutical ... ketorolac tromethamine ophthalmic solution, 0.5% ...ug Administration (FDA) for Sun Pharma,s Abbreviat...#174; opthalmic solution on the first day followin... therapeutically equivalent to Acular® Ophtha...
(Date:11/5/2009)..., Calif., Nov. 5 Transce...alty pharmaceutical company focused on the develop... that address important therapeutic needs in the f... a webcast and teleconference with management to d...rsday, November 12, 2009, at 5:00 p.m. Eastern Sta...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees 13190 1Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees 13190 2Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees 13190 3San Francisco Bay Area Affiliate of the Susan G Komen for the Cure Funds Over 241 2 Million This Year to Community Outreach Programs 52668 1San Francisco Bay Area Affiliate of the Susan G Komen for the Cure Funds Over 241 2 Million This Year to Community Outreach Programs 52668 2San Francisco Bay Area Affiliate of the Susan G Komen for the Cure Funds Over 241 2 Million This Year to Community Outreach Programs 52668 3San Francisco Bay Area Affiliate of the Susan G Komen for the Cure Funds Over 241 2 Million This Year to Community Outreach Programs 52668 4Babies Can Comprehend Canine Language 52664 1Babies Can Comprehend Canine Language 52664 2
Bateman Rongeur
Sundt Slim-Line Temporary Aneurysm Clip
Micro Needle Holders With Lock
Vascular Clamps B-3
Medicine Products: